Mar 8 • 10:13 UTC 🇦🇷 Argentina La Nacion (ES)

Who is Marina Simian: the Argentine scientist working to detect breast cancer with a simple blood test

Marina Simian, an Argentine scientist, is dedicated to developing a simple blood test for breast cancer detection, reflecting on her challenging yet rewarding career path on International Women's Day.

Marina Simian, a 54-year-old Argentine researcher, celebrates her achievements in the field of science as she shares her journey toward developing a life-saving breast cancer detection tool through a simple blood test. Reflecting on her career on International Women’s Day, she emphasizes the importance of perseverance and dedication in overcoming challenges she has faced along the way. Simian’s passion for biology started at a young age, and her exceptional academic performance earned her a scholarship to study marine biology in the United States, offering her early exposure to the sciences.

Throughout her education, particularly during her studies at the Faculty of Exact and Natural Sciences at the University of Buenos Aires (UBA), Simian found a mentor in renowned biologist Alberto Kornblihtt, who ignited her interest in molecular and cellular biology. This connection played a pivotal role in shaping her career, leading her to delve deeper into the biological sciences. Now, she is focused on her research aimed at revolutionizing breast cancer diagnosis, hoping to create an innovative and accessible health tool that could significantly improve patient outcomes.

Simian’s work not only highlights her scientific accomplishments but also serves as an inspiration for women in STEM fields. As she advocates for the importance of accessibility in healthcare through her research, her story emphasizes how dedication and hard work can lead to groundbreaking innovations that could save lives. By sharing her experiences and aspirations, she aims to encourage future generations of female scientists to pursue their passions and contribute to advancements in medical science.

📡 Similar Coverage